Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[rkp72]

The management change is very good news indeed. PP was getting well past it and JW had too much negative image surrounding him. Mullen is reputed to be a great scientist, but how ell will he do as a CEO? Only time will tell. Hopefully he will have enough experts around him to help him make decisions on areas where he has little experience.

The main question is cash. Where is STSI going to get all this money from for the very expensive clinical trials? It has to be through collaboration with a pharma. That pharma will want a large piece of the pie and that is probably the reason for the proposed increase in the number of shares. I fear that this may be just be the first step in the dilution process. Unfortunately the low stock price means greater dilution,